events.endpts.com Open in urlscan Pro
2a05:d018:111a:2c01:c69e:f3f5:a8df:1c17  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Menu


 * Home
 * Agenda
 * Virtual Login

JAN 8-9, 2024
MARRIOTT MARQUIS
780 Mission St, San Francisco, CA


An oasis has emerged in the biopharma money desert as backers look to replenish
capital — still, uncertainty remains on whether it's a mirage or the much needed
dealmaking bump the industry needs. Yet spirits run high as JPM24 marks the
triumphant return of inking strategic alliances and peering into the industry
crystal ball — while keeping an eye out for some major M&A.

We’re back live from San Francisco for JPM Monday and Tuesday — our calendar of
can't-miss panels and fireside chats will feature prominent biopharma leaders to
watch. The Endpoints Hub provides the ultimate coworking space with everything
you need — 1:1 and group meeting spots plus guest pass capabilities and more.
Join us in-person at the Endpoints Hub or watch online to stay plugged into all
the action.




Watch On Demand


SPONSORED BY



For sponsorship opportunities contact Ryan McRae

Get the inside scoop on the shifting R&D landscape from the leaders shaping
biopharma's future

Join the Endpoints Hub — a home base at the center of the action in San
Francisco

Up your networking game with transferable guest passes for colleagues to access
sessions + coworking

Can’t make it to SF? Tune in online by signing up for our livestream sessions


MONDAY, JAN 8 7:00AM - 5:00PM PST

Join Endpoints on Monday as we sit down with leading minds in research,
investing and deal making. Our Monday sessions will feature some of pharma’s top
M&A execs, a view from the top at one of biotech’s creation engines, a candid
look at the capital raising process at two up-and-coming companies and inside
perspectives from the activist and M&A world. 

The Endpoints Hub will be open for coworking & networking — power up your
devices, check email and grab coffee and a bite between session.


View Monday agenda

FEATURING

Carolyn Bertozzi
Prof. of Chemistry and Baker Family Director of Sarafan ChEM-H
Stanford University
Marc Steinberg
Senior Portfolio Manager
Elliott Investment Management
Mikael Dolsten
Chief Scientific Officer, President, Pfizer Research & Development
Pfizer
Noubar Afeyan
Founder & CEO / Co-Founder & Chairman
Flagship Pioneering / Moderna
Glenn Hunzinger
Pharmaceutical & Life Sciences Consulting Solutions Leader
PwC US
Rachna Khosla
SVP, Head of Business Development
Amgen
Thomas Clozel
Co-Founder & CEO
Owkin
James Sabry
Global Head of Pharma Partnering
Roche
E. Eric Tokat
Co-President, Investment Banking
Centerview Partners
Alessandro Maselli
President & CEO
Catalent
Ray Pressburger
North America Life Sciences Industry Lead & Global Life Sciences Strategy Lead
Accenture
Michael Henderson
CEO
Apogee Therapeutics
Venkat Sethuraman
SVP, Global Biometrics & Data Sciences
Bristol Myers Squibb
Devang Bhuva
SVP, Corporate Development
Gilead Sciences, Inc.
Frank O. Nestle
Global Head of Research & Chief Scientific Officer
Sanofi
Matthias Evers
Chief Business Officer
Evotec
Andrew Dunn
Biopharma Correspondent
Endpoints News
Kyle LaHucik
Senior Reporter
Endpoints News
Nicole DeFeudis
Editor
Endpoints News
Arsalan Arif
Founder & Publisher
Endpoints News
Drew Armstrong
Executive Editor
Endpoints News
John Carroll
Founder & Editor
Endpoints News



TUESDAY, JAN 97:00AM - 5:00PM PST

On Tuesday, you’ll go to biotech downturn survival school, hear about the data
private investors expect to see in a tricky capital market and find out the
future plans for pharma from top execs in the industry.

The Endpoints Hub will be open for a second day of coworking & networking —
check out our transferable guest pass option.


View tuesday agenda



FEATURING

Tim Wentworth
CEO
Walgreens Boots Alliance, Inc.
Merdad Parsey
Chief Medical Officer
Gilead Sciences
Fiona Marshall
President, Biomedical Research
Novartis
Carl Gordon
Managing Partner
OrbiMed Advisors
Marianne De Backer
CEO
Vir Biotechnology
Aradhana Sarin
CFO & Executive Director
AstraZeneca
Lucas Dennis
SVP, Head of Research and Development
Foundation Medicine
Eliav Barr
SVP, Head of Global Clinical Development & Chief Medical Officer
Merck
Peter Lebowitz
Former Global Head of Oncology R&D
Johnson & Johnson
JJ Kang
CEO
Appia Bio
Pamela Carroll
COO
Isomorphic Labs
Kailash Swarna
Managing Director & Global Life Sciences Clinical Development Lead
Accenture
Alicyn Campbell
Chief Scientific Officer
Evinova, a Healthtech Subsidiary of the AstraZeneca Group
Joshua Boger
Executive Chair
Alkeus Pharmaceuticals, Inc.
Jorge Conde
General Partner
Andreessen Horowitz
Jeb Keiper
President and CEO
Nimbus Therapeutics
Lydia Ramsey Pflanzer
Deputy Editor
Endpoints News
Andrew Dunn
Biopharma Correspondent
Endpoints News
Drew Armstrong
Executive Editor
Endpoints News
John Carroll
Founder & Editor
Endpoints News





WHAT IS THE ENDPOINTS HUB?

Your home base during JPM — located in the heart of San Francisco at the
Marriott Marquis. Coworking zone, meeting spaces, coffee, light bites, charging
stations and more — buy a transferable guest pass and bring your colleagues.

COWORKING SPACE

The Endpoints Hub provides the ultimate space with everything you need for
meetings and small groups. Meet fellow readers and the Endpoints team while
utilizing our coworking space — coffee, beverages, light bites + meals served
throughout the day. 1:1 private spaces available for reservation at no cost.
Bring your colleagues using our guest pass ticket option.

GUEST PASSES

Need to hold a quick meeting? Get the flexibility to buy a discounted guest pass
that will let you bring colleagues in and out of the Endpoints Hub. Transferable
guest passes allow for different guests to rotate in and out for your meeting
needs. Utilize our 1:1 private spaces available for reservation at no cost.



Privacy Policy



Privacy Policy